Anemocyte is pleased to announce its role as a co-founding member of the newly established European RNA Alliance (ERA), a strategic initiative designed to strengthen Europe’s RNA ecosystem and deliver specialized, high-quality RNA solutions to key international markets and global biopharma hubs.
RNA technologies are increasingly central to modern medicine, driving advances in therapeutics, diagnostics, disease monitoring, prophylaxis and personalized treatments. While Europe is home to world-class expertise across the entire RNA value chain, these capabilities have historically been distributed across independent specialized companies.
ERA brings this expertise together through a unified gateway, giving global pharma companies, biotech innovators, core facilities and research teams direct access to specialized European technologies and scientific know-how.
Connecting European Expertise to Global Markets
Alongside Anemocyte, ERA brings together six founding companies: Genevia Technologies, Immagina Biotechnology, Lexogen, MultiplexDX, siTOOLS Biotech, and TAmiRNA.
Together, the alliance offers complementary capabilities across bioinformatics, translational research, molecular tools, diagnostics, enabling technologies, and advanced biomanufacturing.
While rooted in European scientific excellence, ERA is designed to support global ambitions, acting as an agile partner for international organizations seeking high-quality RNA workflows for research, development and biopharmaceutical applications.
Direct Support for High-Impact Projects
A defining feature of ERA is its commitment to tailored scientific proximity, giving partners direct access to specialized expertise and hands-on support for complex projects.
- Tailored Scientific Guidance: Direct collaboration with specialist scientists to support customized project planning and experimental design.
- Integrated Solutions: Streamlined access to complementary expertise spanning the RNA value chain.
- Global Reach, European Roots: Keeping high-value R&D, biomanufacturing and technical know-how rooted in Europe while supporting partners worldwide.
- Ecosystem Growth: Fostering collaboration through advisory panels, workshops and mentorship initiatives for emerging RNA startups and researchers.
Read the full press release and learn more about ERA here:
Website: www.rnaalliance.eu
Press release: https://www.rnaalliance.eu/news/era-launch
Linkedin Profile: https://www.linkedin.com/company/european-rna-alliance/home/
